Articles related to Psychiatry
FDA approves TMS as form of OCD treatment
NeuroStar is the first FDA-approved transcranial magnetic stimulation (TMS) system developed to treat major depressive disorders. With the new FDA approval, this TMS system will allow physicians to better treat patients with obsessive compulsive disorder (OCD) without the need for additional hardware.
Neurology May 17th 2022
“There’s a Real Risk There”: Cannabis Use Exacerbates Depression
Cannabis use increases the likelihood that patients will develop several negative health conditions, such as insomnia, anxiety, psychosis, and depression. As such, cannabis use should be prescribed carefully by physicians.
Family Medicine/General Practice May 10th 2022
Meta-Analysis of Suicidality in Placebo-Controlled Clinical Trials of Adults Taking Bupropion
A new case study that analyzed the correlation between the use of antidepressants and suicide concluded that all patients treated with antidepressants should receive careful monitoring for clinical worsening, suicidality, or unusual changes in behavior.
Psychiatry May 10th 2022
Was Will Smith’s Slap a Trauma Response?
There’s been a strong response to actor Will Smith’s behavior at this year’s Academy Awards, including in the medical community. In this article, psychiatrist Melissa Hankins analyzes the psychology behind the “slap heard around the world.” And commenting readers disagree vehemently.
Family Medicine/General Practice April 12th 2022
Sleep Academy Warns Lawmakers About Health Risks of Permanent Daylight-Saving Time
The American Academy of Sleep Medicine (AASM) is taking issue with the US Senate’s recently passed legislation that will make daylight saving time (DST) permanent starting in 2023. AASM cautions that this permanent change would lead to health risks that include adverse cardiovascular events, mood disorders, and motor vehicle crashes. The group advocates for establishing permanent standard time instead.
Cardiology March 22nd 2022
Risks of Mental Health Outcomes in People with COVID-19: Cohort Study
The British Medical Journal reports that people who survive COVID-19 are at increased risk of an array of mental health disorders, including anxiety, depression, and opioid use disorder, cognitive decline, sleep disorders, and more. The authors recommend close monitoring of patients following infection and up-prioritizing managing their mental health disorders.
Allergy & Immunology March 1st 2022